They recognize peptide antigens in Class I MHC I molecules. CD8+ T cells inhibit cancer growth, and in the majority of cancers, CD8+ T cells are associated with favorable prognosis and disease-free survival [2,13-18]. Here, CD8A is linked to cancer.